Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „Revlimid“
Suchtreffer
Begriffe & Kennungen
Revlimid · 4.8 · Lenalidomide maintenance after ASCT is associated with a higher frequency of Grade 3 or 4 thrombocytopenia com
Eintrag öffnenRevlimid · 4.8 · Lenalidomide maintenance after ASCT is associated with a higher frequency of Grade 4 neutropenia compared to p
Eintrag öffnenRevlimid · 4.8 · Mantle cell lymphoma The overall safety profile of lenalidomide in patients with mantle cell lymphoma is based
Eintrag öffnenRevlimid · 4.8 · Most adverse reactions tended to occur during the first 16 weeks of therapy with lenalidomide.
Eintrag öffnenRevlimid · 4.8 · Multiple myeloma: patients with at least one prior therapy In two phase 3 placebo-controlled studies, 353 pati
Eintrag öffnenRevlimid · 4.8 · Myelodysplastic syndromes The overall safety profile of lenalidomide in patients with myelodysplastic syndrome
Eintrag öffnenRevlimid · 4.8 · Myocardial infarction Myocardial infarction has been reported in patients receiving lenalidomide, particularly
Eintrag öffnenRevlimid · 4.8 · Neutropenia and thrombocytopenia • Newly diagnosed multiple myeloma: patients who have undergone ASCT treated
Eintrag öffnenRevlimid · 4.8 · Newly diagnosed multiple myeloma: patients who are not eligible for transplant treated with lenalidomide in co
Eintrag öffnenRevlimid · 4.8 · Newly diagnosed multiple myeloma: patients who are not eligible for transplant treated with lenalidomide in co
Eintrag öffnenRevlimid · 4.8 · Not Known Leukocytoclastic vasculitis, Drug Reaction with Eosinophilia and Systemic Symptoms^
Eintrag öffnenRevlimid · 4.8 · Not Known Solid organ transplant rejection
Eintrag öffnenRevlimid · 4.8 · Psychiatric Disorders Common Depression, Insomnia Nervous System Very Common Common Disorders Headache, Dizzin
Eintrag öffnenRevlimid · 4.8 · Rhabdomyolysis Rare cases of rhabdomyolysis have been observed, some of them when lenalidomide is administered
Eintrag öffnenRevlimid · 4.8 · Second primary malignancies In clinical trials in previously treated myeloma patients with lenalidomide/dexame
Eintrag öffnenRevlimid · 4.8 · Summary of the safety profile Newly diagnosed multiple myeloma: patients who have undergone ASCT treated with
Eintrag öffnenRevlimid · 4.8 · Table 1. ADRs reported in clinical trials in patients with multiple myeloma treated with lenalidomide maintena
Eintrag öffnenRevlimid · 4.8 · Table 2. ADRs reported in clinical studies in patients with multiple myeloma treated with lenalidomide in comb
Eintrag öffnenRevlimid · 4.8 · Table 3. ADRs reported in clinical trials in patients with myelodysplastic syndromes treated with lenalidomide
Eintrag öffnenRevlimid · 4.8 · Table 4. ADRs reported in clinical trials in patients with mantle cell lymphoma treated with lenalidomide Syst
Eintrag öffnen